Patent · US Active

Pyridine derivatives

US10308659B2 · kind B2 · utility

6Cited by

3References

10Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Olivier Gavelle · Hagenthal-le-Bas, FR
Uwe Grether · Weil am Rhein, DE
Atsushi Kimbara · Tokyo, JP
Matthias Nettekoven · Weil am Rhein, DE
Roever Stephan · Inzlingen, DE
Mark Rogers-Evans · Bottmingen, CH
Didier Rombach · Mulhouse, FR
Tanja Schulz-Gasch · Ziefen, CH

Key dates

Filing date	Sep 28, 2015
Grant date	Jun 4, 2019
Priority date	—
Expiry date	Sep 28, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I) wherein A and R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.